Impact of prolonged and early bevacizumab treatment on the overall survival of EGFR‐mutant and EGFR‐wild type nonsquamous non‐small cell lung cancer

BACKGROUND: VEGF plays a key role in tumor angiogenesis and immunosuppression. VEGF‐blocking has proven beneficial for EGFR mutant and wild‐type nonsquamous non‐small cell lung cancer (nonsq‐NSCLC); however, the number of cycles and treatment line yielding the optimal benefit are unknown. METHODS: W...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Yu‐Chen, Shen, Shih‐Min, Liu, Chien‐Ying, Pavlidis, Stelios, Wang, Chih‐Liang, Ko, How‐Wen, Chung, Fu‐Tsai, Lin, Tin‐Yu, Feng, Po‐Hao, Lee, Kang‐Yun, Guo, Yi‐Ke, Yang, Cheng‐Ta, Kuo, Chih‐Hsi Scott
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2018
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6275835/
https://www.ncbi.nlm.nih.gov/pubmed/30259696
http://dx.doi.org/10.1111/1759-7714.12875

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6275835/
https://www.ncbi.nlm.nih.gov/pubmed/30259696
http://dx.doi.org/10.1111/1759-7714.12875

Ejemplares similares